Substrates for peptidase M10.002: matrix metallopeptidase-8
Peptide and protein substrates that are thought to be physiologically relevant are indicated by P. Peptide and protein substrates that are thought to be pathologically relevant are indicated by D. Peptide and protein substrates that are not physiologically relevant are indicated by N. Synthetic substrates are indicated by S. Click on the symbol to show only physiological, non-physiological or synthetic substrates, or here to display all substrates. How cleavage sites have been identified are indicated by the following evidence codes: NT = N-terminal sequencing, MS = mass spectroscopy, MU = mutation, CS = consensus sequence, LC = liquid chromatography. To see all annotated cleavages for a protein substrate, click on the UniProt Accession.
| Substrate | Uniprot | Residue range | Cleavage Site | Cleavage type | Evidence | P4 | P3 | P2 | P1 | P1' | P2' | P3' | P4' | Reference | CutDB | MERNUM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| aggrecan core protein | P16112 | 17-2415 | peptide-Asn360+Phe-peptide | P | Ile | Pro | Glu | Asn | Phe | Phe | Gly | Val | Fosang et al., 1996 | 3219 | ||
| aggrecan core protein | P16112 | 17-2415 | peptide-Glu392+Ala-peptide | P | Thr | Glu | Gly | Glu | Ala | Arg | Gly | Ser | Fosang et al., 1996 | 3218 | ||
| aggrecan core protein | P16112 | 17-2415 | peptide-Asp460+Leu-peptide | P | Thr | Ser | Glu | Asp | Leu | Val | Val | Gln | Fosang et al., 1996 | 18237 | ||
| Aggrecan core protein | Q29011 | 1-537 | peptide-Asn344+Phe-peptide | P | NT | Ile | Pro | Glu | Asn | Phe | Phe | Gly | Val | Fosang et al., 1993 | ||
| Aggrecan core protein | Q29011 | 1-537 | peptide-Asp447+Leu-peptide | P | NT | Thr | Ser | Glu | Asp | Leu | Val | Val | Gln | Fosang et al., 1993 | ||
| Alpha-1-antichymotrypsin | P01011 | 24-423 | Peptide-Ala385+Leu-Peptide | P | NT | Leu | Leu | Ser | Ala | Leu | Val | Glu | Thr | Desrochers et al., 1992 | ||
| alpha-1-peptidase inhibitor | P01009 | 25-418 | peptide-Phe376+Leu-peptide | P | Gly | Ala | Met | Phe | Leu | Glu | Ala | Ile | Knauper et al., 1990 | 19087 | ||
| alpha-1-peptidase inhibitor | P01009 | 25-418 | peptide-Pro381+Met-peptide | P | Glu | Ala | Ile | Pro | Met | Ser | Ile | Pro | Knauper et al., 1990 | 19719 | ||
| Angiotensin-1 | P01019 | 34-43 | peptide-Phe41+His-Leu | P | NT | Ile | His | Pro | Phe | His | Leu | - | - | Diekmann & Tschesche, 1994 | ||
| Angiotensin-1 | P01019 | 34-43 | peptide-Pro40+Phe-His-Leu | P | NT | Tyr | Ile | His | Pro | Phe | His | Leu | - | Diekmann & Tschesche, 1994 | ||
| apolipoprotein A-I | P02647 | 19-267 | peptide-Glu215+Tyr-peptide | P | MS | Arg | Leu | Ala | Glu | Tyr | His | Ala | Lys | Salminen et al., 2015 | ||
| apolipoprotein A-I | P02647 | 19-267 | peptide-Val245+Leu-peptide | P | MS | Leu | Leu | Pro | Val | Leu | Glu | Ser | Phe | Salminen et al., 2015 | ||
| biglycan | P21810 | 38-368 | peptide-Glu196+Asn-peptide | P | MS | Asn | Pro | Leu | Glu | Asn | Ser | Gly | Phe | Zhen et al., 2008 | 22369 | |
| biglycan | P21810 | 38-368 | peptide-Asn211+Tyr-peptide | P | MS | Leu | Lys | Leu | Asn | Tyr | Leu | Arg | Ile | Zhen et al., 2008 | 22370 | |
| biglycan | P21810 | 38-368 | peptide-Tyr212+Leu-peptide | P | MS | Lys | Leu | Asn | Tyr | Leu | Arg | Ile | Ser | Zhen et al., 2008 | 22371 | |
| Bradykinin | P01042 | 381-389 | Arg-Pro-Pro-Gly-Phe-Ser-Pro+Phe-Arg | P | NT | Gly | Phe | Ser | Pro | Phe | Arg | - | - | Diekmann & Tschesche, 1994 | ||
| Bradykinin | P01042 | 381-389 | Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe+Arg | P | NT | Phe | Ser | Pro | Phe | Arg | - | - | - | Diekmann & Tschesche, 1994 | ||
| brevican core protein precursor | P55068 | 23-833 | peptide-Ala360+Phe-peptide | P | His | Pro | Ser | Ala | Phe | Ser | Glu | Ala | Nakamura et al., 2001 | 18217 | ||
| C-X-C motif chemokine 10 | P02778 | 22-98 | peptide-Glu92+Arg-peptide | P | NT | Val | Ser | Lys | Glu | Arg | Ser | Lys | Arg | Van den Steen et al., 2003 | ||
| C-X-C motif chemokine 10 | P02778 | 22-98 | peptide-Ser94+Lys-peptide | P | NT | Lys | Glu | Arg | Ser | Lys | Arg | Ser | Pro | Van den Steen et al., 2003 | ||
| C-X-C motif chemokine 11 | O14625 | 22-94 | peptide-Phe25+Lys-peptide | P | Phe | Pro | Met | Phe | Lys | Arg | Gly | Arg | Cox et al., 2008 | |||
| C-X-C motif chemokine 11 | O14625 | 22-94 | peptide-Ser79+Lys-peptide | P | Asn | Pro | Lys | Ser | Lys | Gln | Ala | Arg | Cox et al., 2008 | |||
| C-X-C motif chemokine 11 | O14625 | 22-94 | peptide-Leu84+Ile-peptide | P | Gln | Ala | Arg | Leu | Ile | Ile | Lys | Lys | Cox et al., 2008 | |||
| C-X-C motif chemokine 11 precursor | Q9JHH5 | 22-100 | peptide-Phe25+Lys-peptide | P | Phe | Leu | Met | Phe | Lys | Gln | Gly | Arg | Cox et al., 2008 | |||
| C-X-C motif chemokine 11 precursor | Q9JHH5 | 22-100 | peptide-Leu84+Ile-peptide | P | Gln | Ala | Arg | Leu | Ile | Met | Gln | Ala | Cox et al., 2008 | |||
| C-X-C motif chemokine 11 precursor | Q9JHH5 | 22-100 | peptide-Phe94+Leu-peptide | P | Lys | Lys | Asn | Phe | Leu | Arg | Arg | Gln | Cox et al., 2008 | |||
| C-X-C motif chemokine 5 | P42830 | 37-114 | peptide-Val43+Leu-peptide | P | Ala | Ala | Ala | Val | Leu | Arg | Glu | Leu | Tester et al., 2007 | 21349 | ||
| C-X-C motif chemokine 5 | P50228 | 41-132 | Ala-Pro-Ser-Ser44+Val-peptide | P | NT | Ala | Pro | Ser | Ser | Val | Ile | Ala | Ala | Tester et al., 2007 | ||
| C-X-C motif chemokine 5 | P50228 | 41-132 | peptide-Lys119+Arg-peptide | P | NT | Lys | Lys | Ala | Lys | Arg | Asn | Ala | Leu | Tester et al., 2007 | ||
| collagen alpha 2(I) chain | P02465 | 80-1100 | peptide-Gly775+Leu-peptide | P | Gly | Pro | Gln | Gly | Leu | Leu | Gly | Ala | Aimes & Quigley, 1995 | |||
| collagen alpha-1(I) chain | P02452 | 162-1218 | peptide-Gly775+Ile-peptide | P | Gly | Pro | Gln | Gly | Ile | Ala | Gly | Gln | Krane, 1995 | 16540 | ||
| collagen alpha-1(II) chain | P02458 | 182-1241 | peptide-Gly930+Ala-peptide | P | MS | Gly | Pro | Lys | Gly | Ala | Arg | Gly | Asp | Zhen et al., 2008 | 22815 | |
| collagen alpha-1(II) chain | P02458 | 182-1241 | peptide-Gly975+Leu-peptide | P | MS | Gly | Pro | Gln | Gly | Leu | Ala | Gly | Gln | Zhen et al., 2008 | 22820 | |
| collagen alpha-1(II) chain | P02458 | 182-1241 | peptide-Gly342+Ala-peptide | P | MS | Gly | Ala | Ala | Gly | Ala | Arg | Gly | Asn | Zhen et al., 2008 | 22826 | |
| collagen alpha-1(II) chain | P02458 | 182-1241 | peptide-Gly381+Ala-peptide | P | MS | Gly | Pro | Thr | Gly | Ala | Arg | Gly | Pro | Zhen et al., 2008 | 22828 | |
| collagen alpha-1(II) chain | P02458 | 182-1241 | peptide-Gly1191+Arg-peptide | P | MS | Gly | Pro | Arg | Gly | Arg | Ser | Gly | Glu | Zhen et al., 2008 | 22939 | |
| collagen alpha-1(II) chain | P02458 | 182-1241 | peptide-Ala1222+Phe-peptide | P | MS | Asp | Met | Ser | Ala | Phe | Ala | Gly | Leu | Zhen et al., 2008 | 22943 | |
| collagen alpha-1(II) chain | P02458 | 182-1241 | peptide-Gly561+Leu-peptide | P | MS | Gly | Ala | Arg | Gly | Leu | Thr | Gly | Arg | Zhen et al., 2008 | 22965 | |
| collagen alpha-1(II) chain | P02458 | 182-1241 | peptide-Gly1026+Leu-peptide | P | MS | Gly | Pro | Pro | Gly | Leu | Thr | Gly | Pro | Zhen et al., 2008 | 22976 | |
| collagen alpha-1(II) chain | P02458 | 182-1241 | peptide-Gly1053+Val-peptide | P | MS | Gly | Ala | Ala | Gly | Val | Lys | Gly | Asp | Zhen et al., 2008 | 22983 | |
| collagen alpha-1(II) chain | P02458 | 182-1241 | peptide-Gly627+Leu-peptide | P | MS | Gly | Ala | Pro | Gly | Leu | Arg | Gly | Leu | Zhen et al., 2008 | 22993 | |
| collagen alpha-1(II) chain | P02458 | 182-1241 | peptide-Gly663+Phe-peptide | P | MS | Gly | Pro | Ser | Gly | Phe | Gln | Gly | Leu | Zhen et al., 2008 | 23001 | |
| collagen alpha-1(II) chain | P02458 | 182-1241 | peptide-Gly714+Leu-peptide | P | MS | Gly | Ala | Gln | Gly | Leu | Gln | Gly | Pro | Zhen et al., 2008 | 23013 | |
| collagen alpha-1(II) chain | P02458 | 182-1241 | peptide-Gly747+Leu-peptide | P | MS | Gly | Pro | Pro | Gly | Leu | Gln | Gly | Met | Zhen et al., 2008 | 23018 | |
| collagen alpha-1(II) chain | P02458 | 182-1241 | peptide-Gly720+Leu-peptide | P | MS | Gly | Pro | Arg | Gly | Leu | Pro | Gly | Thr | Zhen et al., 2008 | 23022 | |
| collagen alpha-1(II) chain | P02458 | 182-1241 | peptide-Lys1006+Gln-peptide | P | MS | Glu | Pro | Gly | Lys | Gln | Gly | Ala | Pro | Zhen et al., 2008 | 23050 | |
| collagen alpha-1(II) chain | P02458 | 182-1241 | peptide-Gly507+Glu-peptide | P | MS | Gly | Pro | Pro | Gly | Glu | Arg | Gly | Ala | Zhen et al., 2008 | 23074 | |
| collagen alpha-1(II) chain | P02458 | 182-1241 | peptide-Gly537+Leu-peptide | P | MS | Gly | Pro | Ser | Gly | Leu | Ala | Gly | Pro | Zhen et al., 2008 | 23082 | |
| collagen alpha-1(II) chain | P02458 | 182-1241 | peptide-Gly594+Ala-peptide | P | MS | Gly | Pro | Gln | Gly | Ala | Arg | Gly | Gln | Zhen et al., 2008 | ||
| Collagen alpha-1(II) chain isoform 2 | P02458 | 182-1241 | peptide-Gly981+Ile-peptide | P | MS | Gly | Gln | Arg | Gly | Ile | Val | Gly | Leu | Zhen et al., 2008 | 23044 | |
| collagen alpha-1(III) chain | P02461 | 154-1221 | peptide-Gly948+Ile-peptide | P | MS | Gly | Pro | Leu | Gly | Ile | Ala | Gly | Ile | Zhen et al., 2008 | 22881 | |
| collagen alpha-1(III) chain | P02461 | 154-1221 | peptide-Gly975+Val-peptide | P | MS | Gly | Pro | Gln | Gly | Val | Lys | Gly | Glu | Zhen et al., 2008 | 22882 | |
| collagen alpha-1(III) chain | P02461 | 154-1221 | peptide-Gly741+Asp-peptide | P | MS | Gly | Pro | Lys | Gly | Asp | Lys | Gly | Glu | Zhen et al., 2008 | 22883 | |
| collagen alpha-1(III) chain | P02461 | 154-1221 | peptide-Gly774+Gln-peptide | P | MS | Gly | Pro | Ala | Gly | Gln | Pro | Gly | Asp | Zhen et al., 2008 | 22886 | |
| collagen alpha-1(III) chain | P02461 | 154-1221 | peptide-Gly1128+Ala-peptide | P | MS | Gly | Gln | Gln | Gly | Ala | Ile | Gly | Ser | Zhen et al., 2008 | 22888 | |
| collagen alpha-1(III) chain | P02461 | 154-1221 | peptide-Gly1149+Lys-peptide | P | MS | Gly | Pro | Pro | Gly | Lys | Asp | Gly | Thr | Zhen et al., 2008 | 22889 | |
| collagen alpha-1(III) chain | P02461 | 154-1221 | peptide-Gly1125+Gln-peptide | P | MS | Gly | Pro | Ala | Gly | Gln | Gln | Gly | Ala | Zhen et al., 2008 | ||
| Dabcyl-Leu-Ala-Gln-Ala-HPh-Arg-Ser-Lys(Fam)-NH2 | Dabcyl-Leu-Ala-Gln-Ala+HPh-Arg-Ser-Lys(Fam)-NH2 | S | Leu | Ala | Gln | Ala | HPh | Arg | Ser | LyN | Moss & Rasmussen, 2007 | |||||
| Dabcyl-Pro-Arg-Ala-Ala-Ala-hPhe-Thr-Ser-Pro-Lys(FAM)-NH2 | Dabcyl-Pro-Arg-Ala-Ala-Ala+homoPhe-Thr-Ser-Pro-Lys(FAM)-NH2 | S | Arg | Ala | Ala | Ala | HPh | Thr | Ser | Pro | Moss et al., 2016 | |||||
| Dabcyl-Ser-Pro-Leu-Ala-Gln-Ala-Val-Arg-Ser-Ser-Lys(FAM)-NH2 | Dabcyl-Ser-Pro-Leu-Ala-Gln-Ala+Val-Arg-Ser-Ser-Lys(FAM)-NH2 | S | Leu | Ala | Gln | Ala | Val | Arg | Ser | Ser | Moss et al., 2016 | |||||
| Dnp-Pro-Gln-Gly-Ile-Ala-Gly-Gln-D-Arg-OH | Dnp-Pro-Gln-Gly+Ile-Ala-Gly-Gln-D-Arg-OH | S | - | Pro | Gln | Gly | Ile | Gln | Gly | - | Tschesche et al., 2004 | |||||
| Dnp-Pro-Leu-Gly-Leu-Trp-Ala-D-Arg-NH2 | Dnp-Pro-Leu-Gly+Leu-Trp-Ala-D-Arg-NH2 | S | - | Pro | Leu | Gly | Leu | Trp | Ala | DAr | Tschesche et al., 2004 | |||||
| Ephrin-B1 | P98172 | 28-346 | peptide-Lys217+Ser-peptide | P | MS | Gln | Glu | Glu | Lys | Ser | Gly | Pro | Gly | Tanaka et al., 2007 | ||
| fibrinogen alpha chain | P02671 | 36-866 | peptide-Glu441+Leu-peptide | P | Gly | Asp | Lys | Glu | Leu | Arg | Thr | Gly | Hiller et al., 2000 | 18435 | ||
| fibrinogen alpha chain precursor | P02671 | 1-866 | peptide-Thr19+Ala-peptide | P | Thr | Ala | Trp | Thr | Ala | Asp | Ser | Gly | Hiller et al., 2000 | 18434 | ||
| fibronectin | P02751 | 32-2386 | peptide-Pro627+Ile-peptide | P | MS | Asn | Ser | His | Pro | Ile | Gln | Trp | Asn | Zhen et al., 2008 | 22483 | |
| fibronectin | P02751 | 32-2386 | peptide-Glu613+Val-peptide | P | MS | Gly | Pro | Val | Glu | Val | Phe | Ile | Thr | Zhen et al., 2008 | 22484 | |
| fibronectin | P02751 | 32-2386 | peptide-Pro720+Leu-peptide | P | NT | Pro | Phe | Ser | Pro | Leu | Val | Ala | Thr | Doucet & Overall, 2010 | ||
| fibronectin | P02751 | 32-2386 | peptide-Ala291+Ala-peptide | P | NT | Asp | Val | Arg | Ala | Ala | Val | Tyr | Gln | Doucet & Overall, 2010 | ||
| fibronectin | P02751 | 32-2386 | peptide-Thr1249+Val-peptide | P | NT | Ser | Val | Tyr | Thr | Val | Lys | Asp | Asp | Doucet & Overall, 2010 | ||
| fibronectin | P02751 | 32-2386 | peptide-Pro1258+Ile-peptide | P | NT | Glu | Ser | Val | Pro | Ile | Ser | Asp | Thr | Doucet & Overall, 2010 | ||
| fibronectin | P02751 | 32-2386 | peptide-Ala44+Val-peptide | P | NT | Ser | Pro | Val | Ala | Val | Ser | Gln | Ser | Doucet & Overall, 2010 | ||
| fibronectin | P02751 | 32-2386 | peptide-Gln47+Ser-peptide | P | MS | Ala | Val | Ser | Gln | Ser | Lys | Pro | Gly | Doucet & Overall, 2010 | ||
| fibronectin | P02751 | 32-2386 | peptide-His1181+Leu-peptide | P | MS | Thr | Asn | Leu | His | Leu | Glu | Ala | Asn | Doucet & Overall, 2010 | ||
| fibronectin | P02751 | 32-2386 | peptide-Pro1186+Asp-peptide | P | MS | Glu | Ala | Asn | Pro | Asp | Thr | Gly | Val | Doucet & Overall, 2010 | ||
| fibronectin | P02751 | 32-2386 | peptide-Gly2197+Leu-peptide | P | MS | Val | Asn | Glu | Gly | Leu | Asn | Gln | Pro | Doucet & Overall, 2010 | ||
| fibronectin | P02751 | 32-2386 | peptide-Lys2230+Leu-peptide | P | MS | Ser | Gly | Phe | Lys | Leu | Leu | Cys | Gln | Doucet & Overall, 2010 | ||
| Glu(EDANS)-Pro-Leu-Ala-Gln-Ala-Val-Arg-Ser-Ser(TF)-Ser-Lys(DABCYL) | Glu(EDANS)-Pro-Leu-Ala-Gln-Ala+Val-Arg-Ser-Ser(TF)-Ser-Lys(DABCYL) | S | Leu | Ala | Gln | Ala | Val | Arg | Ser | Ser | Minond et al., 2012 | |||||
| Glu(EDANS)-Pro-Leu-Ala-Gln-Ala-Val-Arg-Ser-Ser(TF)-Ser-Lys(DABCYL) | Glu(EDANS)-Pro-Leu-Ala-Gln+Ala-Val-Arg-Ser-Ser(TF)-Ser-Lys(DABCYL) | S | Pro | Leu | Ala | Gln | Ala | Val | Arg | Ser | Minond et al., 2012 | |||||
| Glu(EDANS)-Pro-Leu-Ala-Gln-Ala-Val-Arg-Ser-Ser-Ser-Lys(DABCYL) | Glu(EDANS)-Pro-Leu-Ala-Gln-Ala+Val-Arg-Ser-Ser(TF)-Ser-Lys(DABCYL) | S | Leu | Ala | Gln | Ala | Val | Arg | Ser | Ser | Minond et al., 2012 | |||||
| Gly-Pro-Gln-Gly-Ile-Trp-Gly-Gln | Gly-Pro-Gln-Gly+Ile-Trp-Gly-Gln | N | Gly | Pro | Gln | Gly | Ile | Trp | Gly | Gln | Tschesche et al., 2004 | |||||
| interleukin-8 | P10145 | 23-99 | peptide-Arg27+Ser-peptide | P | Val | Leu | Pro | Arg | Ser | Ala | Lys | Glu | Tester et al., 2007 | 21346 | ||
| laminin subunit gamma-2 | Q61092 | 22-1191 | peptide-Leu607+Thr-peptide | P | His | Ala | Ala | Leu | Thr | Ser | Cys | Pro | Pirilä et al., 2003 | 23318 | ||
| LPS-induced CXC chemokine | Q8K3I3 | 41-132 | peptide-Ser44+Val-peptide | P | Ala | Pro | Ser | Ser | Val | Ile | Ala | Ala | Tester et al., 2007 | 21342 | ||
| LPS-induced CXC chemokine | Q8K3I3 | 41-132 | peptide-Lys119+Arg-peptide | P | Lys | Lys | Ala | Lys | Arg | Asn | Ala | Leu | Tester et al., 2007 | 21344 | ||
| matrix metallopeptidase-8 | P22894 | 101-467 | peptide-Gly262+Leu-peptide | P | Ala | Ile | Tyr | Gly | Leu | Ser | Ser | Asn | Knauper et al., 1993 | 18418 | ||
| matrix metallopeptidase-8 | P22894 | 101-467 | peptide-Pro267+Ile-peptide | P | Ser | Ser | Asn | Pro | Ile | Gln | Pro | Thr | Fosang et al., 1996 | 18419 | ||
| Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 | Mca-Pro-Leu-Gly+Leu-Dpa-Ala-Arg-NH2 | S | Mca | Pro | Leu | Gly | Leu | Dpa | Ala | Arg | Nie & Pei, 2004 | |||||
| myelin basic protein isoform 1 | P02686 | 135-304 | peptide-Phe90+Phe-peptide | P | MS | Val | Val | His | Phe | Phe | Lys | Asn | Ile | Shiryaev et al., 2009 | 25392 | |
| myelin basic protein isoform 1 | P02686 | 135-304 | peptide-Phe91+Lys-peptide | P | MS | Val | His | Phe | Phe | Lys | Asn | Ile | Val | Shiryaev et al., 2009 | 25393 | |
| myelin basic protein isoform 1 | P02686 | 135-304 | peptide-Asn93+Ile-peptide | P | MS | Phe | Phe | Lys | Asn | Ile | Val | Thr | Pro | Shiryaev et al., 2009 | 25394 | |
| myelin basic protein isoform 1 | P02686 | 135-304 | peptide-Gly109+Leu-peptide | P | MS | Lys | Gly | Arg | Gly | Leu | Ser | Leu | Ser | Shiryaev et al., 2009 | 25395 | |
| myelin basic protein isoform 1 | P02686 | 135-304 | peptide-Asp134+Tyr-peptide | P | MS | Arg | Ala | Ser | Asp | Tyr | Lys | Ser | Ala | Shiryaev et al., 2009 | 25396 | |
| myelin basic protein isoform 1 | P02686 | 135-304 | peptide-Lys153+Ile-peptide | P | MS | Thr | Leu | Ser | Lys | Ile | Phe | Lys | Leu | Shiryaev et al., 2009 | 25397 | |
| myelin basic protein isoform 1 | P04370 | 1-246 | peptide-Glu116+Leu-peptide | P | MS | Glu | Ser | Asp | Glu | Leu | Gln | Thr | Ile | Shiryaev et al., 2009 | 25537 | |
| myelin basic protein isoform 1 | P04370 | 1-246 | peptide-Asn75+Asn-peptide | P | MS | Asp | Pro | Lys | Asn | Asn | Trp | Gln | Gly | Shiryaev et al., 2009 | 25538 | |
| myelin basic protein isoform 1 | P04370 | 1-246 | peptide-Ser144+Lys-peptide | P | MS | Ser | Gln | Arg | Ser | Lys | Tyr | Leu | Ala | Shiryaev et al., 2009 | 25539 | |
| myelin basic protein isoform 1 | P04370 | 1-246 | peptide-Pro203+Gln-peptide | P | MS | Gly | Ser | Leu | Pro | Gln | Lys | Ser | Gln | Shiryaev et al., 2009 | 25540 | |
| myelin basic protein isoform 1 | P04370 | 1-246 | peptide-Lys205+Ser-peptide | P | MS | Leu | Pro | Gln | Lys | Ser | Gln | His | Gly | Shiryaev et al., 2009 | 25541 | |
| myelin basic protein isoform 1 | P04370 | 1-246 | peptide-His208+Gly-peptide | P | MS | Lys | Ser | Gln | His | Gly | Arg | Thr | Gln | Shiryaev et al., 2009 | 25542 | |
| myelin basic protein isoform 1 | P02686 | 135-304 | peptide-Tyr15+Leu-peptide | P | MS | Gly | Ser | Lys | Tyr | Leu | Ala | Thr | Ala | Shiryaev et al., 2009 | 25565 | |
| myelin basic protein isoform 2 | P04370-2 | 1-190 | peptide-Lys34+Leu-peptide | P | MS | Ser | Val | Gly | Lys | Leu | Ser | Gln | Thr | Shiryaev et al., 2009 | 25427 | |
| myelin basic protein isoform 2 | P04370-2 | 1-190 | peptide-Asn75+Asn-peptide | P | MS | Asp | Pro | Lys | Asn | Asn | Trp | Gln | Gly | Shiryaev et al., 2009 | 25428 | |
| myelin basic protein isoform 2 | P04370-2 | 1-190 | peptide-Tyr146+Leu-peptide | P | MS | Arg | Ser | Lys | Tyr | Leu | Ala | Thr | Ala | Shiryaev et al., 2009 | 25429 | |
| myelin basic protein isoform 3 | P02686-3 | 1-197 | peptide-Tyr15+Leu-peptide | P | MS | Gly | Ser | Lys | Tyr | Leu | Ala | Thr | Ala | Shiryaev et al., 2009 | 25399 | |
| plasma protease C1 inhibitor | P05155 | 23-500 | peptide-Ala461+Ile-peptide | P | NT | Ala | Ala | Ser | Ala | Ile | Ser | Val | Ala | Knauper et al., 1991 | ||
| prolactin | P01236 | 29-227 | peptide-Leu184+Gln-peptide | P | Leu | Pro | Ser | Leu | Gln | Met | Ala | Asp | Macotela et al., 2006 | 21568 | ||
| prolargin | P51888 | 21-382 | peptide-Asp201+Leu-peptide | P | MS | Leu | Leu | Leu | Asp | Leu | Gln | His | Asn | Zhen et al., 2008 | 22560 | |
| prolargin | P51888 | 21-382 | peptide-Thr216+Phe-peptide | P | MS | Lys | Pro | Asp | Thr | Phe | His | Gly | Leu | Zhen et al., 2008 | 22561 | |
| prolargin | P51888 | 21-382 | peptide-Asn222+Leu-peptide | P | MS | Gly | Leu | Lys | Asn | Leu | Met | Gln | Leu | Zhen et al., 2008 | 22562 | |
| prolargin | P51888 | 21-382 | peptide-Asn172+Leu-peptide | P | MS | Leu | Pro | Arg | Asn | Leu | Glu | Gln | Leu | Zhen et al., 2008 | 22607 | |
| prolargin | P51888 | 21-382 | peptide-Asn181+His-peptide | P | MS | Leu | Ser | Gln | Asn | His | Ile | Ser | Arg | Zhen et al., 2008 | 22608 | |
| QF-24 | Mca-Pro-Leu-Gly+Leu-Dpa-Ala-Arg-NH2 | S | Mca | Pro | Leu | Gly | Leu | Dpa | Ala | Arg | Tschesche et al., 2004 | |||||
| small inducible cytokine B6 | P80162 | 38-114 | peptide-Ala42+Val-peptide | P | Pro | Val | Ser | Ala | Val | Leu | Thr | Glu | Van den Steen et al., 2003 | 18605 | ||
| small inducible cytokine B6 | P80162 | 38-114 | peptide-Val43+Leu-peptide | P | Val | Ser | Ala | Val | Leu | Thr | Glu | Leu | Van den Steen et al., 2003 | 18606 | ||
| Substance P | P20366 | 58-68 | peptide-Gln63+Phe-peptide | P | NT | Lys | Pro | Gln | Gln | Phe | Phe | Gly | Leu | Diekmann & Tschesche, 1994 | ||
| Substance P | P20366 | 58-68 | peptide-Gly66+Leu-Met | P | NT | Gln | Phe | Phe | Gly | Leu | Met | - | - | Diekmann & Tschesche, 1994 | ||
| tissue factor pathway inhibitor | P10646 | 29-304 | peptide-Ser202+Thr-peptide | P | Thr | Pro | Gln | Ser | Thr | Lys | Val | Pro | Cunningham et al., 2002 | 3217 | ||
| tissue factor pathway inhibitor | P10646 | 29-304 | peptide-Lys48+Leu-peptide | P | Pro | Pro | Leu | Lys | Leu | Met | His | Ser | Cunningham et al., 2002 | 3220 | ||
| tumor necrosis factor | P01375 | 72-82 | Pro-Leu-Ala+Gln-Ala-Val-Arg-Ser-Ser-Ser-Arg | N | '-' | Pro | Leu | Ala | Gln | Ala | Val | Arg | Lee &etal, 2014 | |||
| tumor necrosis factor | P01375 | 72-82 | Pro-Leu-Ala-Gln-Ala+Val-Arg-Ser-Ser-Ser-Arg | N | Leu | Ala | Gln | Ala | Val | Arg | Ser | Ser | Lee &etal, 2014 | |||
| [Met-Lys]-bradykinin | P01042 | 379-389 | Met-Lys-Arg-Pro-Pro-Gly-Phe-Ser-Pro+Phe-Arg | P | NT | Gly | Phe | Ser | Pro | Phe | Arg | - | - | Diekmann & Tschesche, 1994 | ||
| [Met-Lys]-bradykinin | P01042 | 379-389 | Met-Lys-Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe+Arg | P | NT | Phe | Ser | Pro | Phe | Arg | - | - | - | Diekmann & Tschesche, 1994 |
